)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Curanex Pharmaceuticals (CURX) investor relations material
Curanex Pharmaceuticals Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary17 Nov, 2025
Executive summary
Completed initial public offering (IPO) on August 27, 2025, raising $13.24 million in net proceeds, with an additional $2.07 million from the over-allotment option exercised in September 2025.
Focused on developing botanical drugs for inflammatory diseases, with Phyto-N as the lead candidate targeting seven core indications.
No revenue generated in the quarter or year-to-date, consistent with pre-commercialization R&D stage.
Net loss for Q3 2025 was $954,059, up from $91,166 in Q3 2024, driven by increased R&D and IPO-related expenses.
Financial highlights
Cash and cash equivalents were $5.83 million as of September 30, 2025, up from $148,891 at December 31, 2024.
Net loss for the nine months ended September 30, 2025, was $1,151,988, compared to $215,567 for the same period in 2024.
R&D expenses for Q3 2025 were $677,474, reflecting IND-enabling studies; G&A expenses were $273,853.
Prepaid R&D totaled $8.5 million as of September 30, 2025, representing advance payments to CROs and CDMOs.
No revenue recognized; all expenses related to R&D and public company readiness.
Outlook and guidance
Anticipates continued significant R&D spending as IND studies progress, with moderation expected until FDA approvals and clinical trials commence.
Existing cash and IPO proceeds expected to fund operations for at least the next twelve months.
Revenue generation expected only upon successful commercialization or strategic licensing agreements.
Nasdaq bid price compliance plan
Future R&D spending moderation strategy
Remediate disclosure control weaknesses
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Curanex Pharmaceuticals earnings date
Q4 20252 Mar, 2026
Next Curanex Pharmaceuticals earnings date
Q4 20252 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage